DE69732402T2 - Zusammensetzung zur Behandlung von Kondyloma Acuminata - Google Patents

Zusammensetzung zur Behandlung von Kondyloma Acuminata Download PDF

Info

Publication number
DE69732402T2
DE69732402T2 DE69732402T DE69732402T DE69732402T2 DE 69732402 T2 DE69732402 T2 DE 69732402T2 DE 69732402 T DE69732402 T DE 69732402T DE 69732402 T DE69732402 T DE 69732402T DE 69732402 T2 DE69732402 T2 DE 69732402T2
Authority
DE
Germany
Prior art keywords
treatment
catechin
condyloma acuminata
acuminata
tea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732402T
Other languages
German (de)
English (en)
Other versions
DE69732402D1 (de
Inventor
Shu Jun Cheng
De Chang Wang
Yukihiko Hara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CANCER INST HOSPITAL CHINESE A
Cancer Hospital and Institute of CAMS and PUMC
Mitsui Norin Co Ltd
Original Assignee
CANCER INST HOSPITAL CHINESE A
Cancer Hospital and Institute of CAMS and PUMC
Mitsui Norin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CANCER INST HOSPITAL CHINESE A, Cancer Hospital and Institute of CAMS and PUMC, Mitsui Norin Co Ltd filed Critical CANCER INST HOSPITAL CHINESE A
Application granted granted Critical
Publication of DE69732402D1 publication Critical patent/DE69732402D1/de
Publication of DE69732402T2 publication Critical patent/DE69732402T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
DE69732402T 1996-11-18 1997-11-18 Zusammensetzung zur Behandlung von Kondyloma Acuminata Expired - Lifetime DE69732402T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32119596 1996-11-18
JP32119596A JP3213557B2 (ja) 1996-11-18 1996-11-18 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤

Publications (2)

Publication Number Publication Date
DE69732402D1 DE69732402D1 (de) 2005-03-10
DE69732402T2 true DE69732402T2 (de) 2006-01-19

Family

ID=18129859

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69732402T Expired - Lifetime DE69732402T2 (de) 1996-11-18 1997-11-18 Zusammensetzung zur Behandlung von Kondyloma Acuminata
DE200912000072 Active DE122009000072I2 (de) 1996-11-18 1997-11-18 Zusammensetzung zur Behandlung von Kondyloma Acuminata.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE200912000072 Active DE122009000072I2 (de) 1996-11-18 1997-11-18 Zusammensetzung zur Behandlung von Kondyloma Acuminata.

Country Status (13)

Country Link
US (1) US5795911A (enExample)
EP (1) EP0842660B1 (enExample)
JP (1) JP3213557B2 (enExample)
KR (1) KR100312252B1 (enExample)
CN (1) CN1086290C (enExample)
AT (1) ATE288266T1 (enExample)
AU (1) AU716120B2 (enExample)
CA (1) CA2221370C (enExample)
DE (2) DE69732402T2 (enExample)
ES (1) ES2232849T3 (enExample)
FR (1) FR12C0077I2 (enExample)
PT (1) PT842660E (enExample)
TW (1) TW371628B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
CN1063957C (zh) 1997-09-29 2001-04-04 北京华颐中药制药厂 一种金荞麦制剂的制备方法
EP1037534A4 (en) 1997-09-29 2005-04-06 China Innovation Ct For Life S FAGOPYRUM CYMOSUM (TREV.) MEISN COMPOSITION, PROCESS FOR PREPARING AND ANALYZING THE SAME AND USES THEREOF
EP0938897A1 (en) * 1997-12-26 1999-09-01 Japanese Foundation For Cancer Research Telomerase inhibitor
US6030622A (en) * 1998-06-23 2000-02-29 Shehadeh; Ahmad Abdallah Herbal extract composition and method with immune-boosting capability
EP1100496A4 (en) * 1998-07-21 2002-10-23 Univ Jefferson SMALL PROTEIN INHIBITOR MOLECULES BCL-2
KR100319973B1 (ko) * 1998-12-05 2002-04-22 이인수 녹차카테킨을 유효성분으로 하는 자궁경부 상피내종양 예방 또는 치료제 조성물
CA2440017A1 (en) 2001-05-03 2002-11-14 Cornell Research Foundation, Inc. Treatment of hpv caused diseases
DE10156794B4 (de) 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
PT1448186E (pt) * 2001-11-19 2009-03-24 Medigene Ag Medicamento para o tratamento de doenças virais da pele e doenças tumorais
US7972632B2 (en) 2003-02-28 2011-07-05 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US7108868B2 (en) 2002-03-22 2006-09-19 Unigen Pharmaceuticals, Inc. Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
EP2108370A1 (en) * 2002-04-30 2009-10-14 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US7780992B2 (en) 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
CN1798568B (zh) 2003-04-04 2011-05-11 尤尼根制药公司 用于哺乳动物皮肤护理的双重环氧合酶(cox)以及脂氧合酶(lox)抑制剂的组合物
US7763588B2 (en) * 2003-06-13 2010-07-27 The Salk Institute For Biological Studies Method for increasing cognitive function and neurogenesis
WO2005020932A2 (en) * 2003-09-02 2005-03-10 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
US7910138B2 (en) 2003-10-09 2011-03-22 Medigene Ag Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin
CN100337690C (zh) * 2005-02-07 2007-09-19 上海复旦张江生物医药股份有限公司 一种评价治疗尖锐湿疣药物有效性的方法
US20070082073A1 (en) * 2005-05-18 2007-04-12 University Of South Florida Catechin Adjuvants
US8044098B2 (en) * 2005-08-02 2011-10-25 Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd. Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
KR100801891B1 (ko) 2006-11-02 2008-02-12 한상진 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
EP2179722A1 (en) 2008-10-24 2010-04-28 Heinrich-Pette-Institut für experimentelle Virologie und Immunologie Topical formation for preventing sexual transmission of viral infection
ES2349966B1 (es) * 2008-10-30 2011-11-18 Ignacio Umbert Millet Formulaciones topicas para el tratamiento de verrugas.
US20110218241A1 (en) * 2010-03-06 2011-09-08 Cacao Bio-Technologies, Llc Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
WO2012100835A1 (en) 2011-01-28 2012-08-02 Laboratorios Del Dr. Esteve, S.A. Methods and compositions for the treatment of aids
WO2014110284A1 (en) 2013-01-09 2014-07-17 Bacterin International, Inc. Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
IL254568B2 (en) 2015-03-19 2023-11-01 Wendy Anne Epstein Catechin compounds extracted from tea leaves for the treatment of female sexual disorders
MX367243B (es) * 2016-02-04 2019-08-09 Maria Del Carmen Ramirez Olvera COMPOSICIÓN DE EXTRACTOS DE PLANTAS QUE INCREMENTAN LOS BACILOS DE DöDERLEIN, USADA PARA EL TRATAMIENTO DE ENFERMEDADES DE TRANSMISIÓN SEXUAL (ETS) Y DEL VIRUS DEL PAPILOMA HUMANO (VPH), CON EFECTO AFRODISIACO.
CN106727275A (zh) * 2016-12-15 2017-05-31 珠海聚焦先导生物研究院有限公司 一种治疗阴道炎的栓剂组合物
CN107349197A (zh) * 2017-07-13 2017-11-17 黄冈师范学院 一种儿茶素在制备治疗皮肤乳头状瘤的药物上的应用
IT202200013867A1 (it) 2022-06-30 2023-12-30 Lo Li Pharma Srl Composizione per il trattamento dell’ infezione da papilloma virus (hpv)
US12111395B2 (en) * 2023-01-30 2024-10-08 Semiconductor Components Industries, Llc Acoustic sensing of proximate obstacles
WO2025227040A1 (en) * 2024-04-26 2025-10-30 Amplexd Therapeutics, Inc. Pharmaceutical compositions and methods for treatment of intraepithelial dysplasia and neoplasia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2128207B1 (enExample) * 1971-03-11 1974-08-02 Zyma Sa
US5159069A (en) * 1988-12-20 1992-10-27 Yamanouchi Pharmaceutical Co., Ltd. Sulfated tannins and their salts
JP2727471B2 (ja) * 1989-09-14 1998-03-11 三井農林株式会社 インフルエンザウィルス感染予防剤
JPH03141220A (ja) * 1989-10-26 1991-06-17 Tsumura & Co 抗レトロウイルス剤
JP3019996B2 (ja) * 1990-03-01 2000-03-15 三井農林株式会社 白癬治療剤
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4211238C2 (de) * 1992-04-03 1994-10-27 Edward I Budowskij Verwendung von 2',5'-Oligoadenylaten zur Behandlung von Papillomatosen
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
GB2293548A (en) * 1994-09-29 1996-04-03 Joan Louise Hibberd Treatment of herpes infections
IT1275905B1 (it) * 1995-03-14 1997-10-24 Indena Spa Frazioni polifenoliche di te', loro uso e formulazioni che le contengono
US5576013A (en) * 1995-03-21 1996-11-19 Eastern Virginia Medical School Treating vascular and neoplastic tissues
JPH1036260A (ja) * 1996-07-18 1998-02-10 Mitsui Norin Kk 抗ガン剤の効力増強方法

Also Published As

Publication number Publication date
AU4443897A (en) 1998-06-04
FR12C0077I2 (fr) 2013-08-16
CA2221370A1 (en) 1998-05-18
AU716120B2 (en) 2000-02-17
CN1185947A (zh) 1998-07-01
CA2221370C (en) 2004-03-02
EP0842660B1 (en) 2005-02-02
PT842660E (pt) 2005-05-31
CN1086290C (zh) 2002-06-19
ES2232849T3 (es) 2005-06-01
KR100312252B1 (ko) 2002-02-19
TW371628B (en) 1999-10-11
JPH10147525A (ja) 1998-06-02
US5795911A (en) 1998-08-18
FR12C0077I1 (enExample) 2013-02-01
ATE288266T1 (de) 2005-02-15
JP3213557B2 (ja) 2001-10-02
DE122009000072I2 (de) 2011-07-21
EP0842660A1 (en) 1998-05-20
DE69732402D1 (de) 2005-03-10
KR19980042555A (ko) 1998-08-17
DE122009000072I1 (de) 2010-03-25

Similar Documents

Publication Publication Date Title
DE69732402T2 (de) Zusammensetzung zur Behandlung von Kondyloma Acuminata
DE69635488T2 (de) Antivirale verbindung
DE69034018T2 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
EP2214658B1 (de) Osmolythaltige zubereitung zur anwendung bei trockenen schleimhäuten
US5968973A (en) Method for treating hyperplasia
DE3783024T2 (de) Topische ofloxacin enthaltende zubereitung.
CN113081928A (zh) 一种植物抑菌凝胶及其制备方法和应用
CN115444815B (zh) 一种pH响应型抑菌缓释凝胶及制备方法
DE69208941T2 (de) Augenpräparate mit verlängerter Freigabe
EP1441755A2 (de) Topikale verwendung von cytokinen und/oder chemokinen zur behandlung von viralen oder mykotischen hauterkrankungen oder tumorerkrankungen
EP1448186B1 (de) Arzneimittel zur behandlung von viralen haut- und tumorerkrankungen
DE69532809T2 (de) Pharmazeutische präparate, insbesondere ovula, die viele verschiedene aktive bestandteile enthalten
Abo-Neima et al. Antibacterial and anti-corona virus (229E) activity of Nigella sativa oil combined with photodynamic therapy based on methylene blue in wound infection: in vitro and in vivo study
DE69606466T2 (de) Verwendung eines Pulvers oder eines Extraktes von Guava zur Behandlung von Allergien
DE3418820C2 (enExample)
EP0326145A1 (de) Silbersulfadiazinhaltiges Mittel zur lokalen äusserlichen Therapie
WO2000033832A1 (en) Chemical composition for treating cervical intraepithelial neoplasia i, ii, iii, iv and cervicitis
EP0527241A1 (de) Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
DE10156794B4 (de) Arzneimittel zur Behandlung von Warzen
DE69923172T2 (de) Behandlung einer papillomavirusinfektion durch verwendung von mycobacterium
DE112012001971T5 (de) Gewichtsreduzierendes Material
EP0294538A2 (de) Verwendung von Nigerizin zur Herstellung eines Mittels zur Behandlung von Virus-Erkrankungen
JPH0240326A (ja) 薬剤組成物及びその調製方法
CN105311600A (zh) 具有杀菌消毒功效的医用凝胶
CN110141609A (zh) 一种用于治疗小儿眼角裂的药膏及其制备方法